Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP387806.RAqRJhYAnXxxTrU310vyfKZX5Ecg-RLHuCEv_7o3HY2W0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP387806.RAqRJhYAnXxxTrU310vyfKZX5Ecg-RLHuCEv_7o3HY2W0130_assertion type Assertion NP387806.RAqRJhYAnXxxTrU310vyfKZX5Ecg-RLHuCEv_7o3HY2W0130_head.
- NP387806.RAqRJhYAnXxxTrU310vyfKZX5Ecg-RLHuCEv_7o3HY2W0130_assertion description "[The analysis showed that 45.8% of typical carcinoid and 28.6% of atypical carcinoid tumors express EGFR, 100% of the tumors lack expression of ErbB2, and 100% have moderate to intense staining for ErbB3 and ErbB4.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP387806.RAqRJhYAnXxxTrU310vyfKZX5Ecg-RLHuCEv_7o3HY2W0130_provenance.
- NP387806.RAqRJhYAnXxxTrU310vyfKZX5Ecg-RLHuCEv_7o3HY2W0130_assertion evidence source_evidence_literature NP387806.RAqRJhYAnXxxTrU310vyfKZX5Ecg-RLHuCEv_7o3HY2W0130_provenance.
- NP387806.RAqRJhYAnXxxTrU310vyfKZX5Ecg-RLHuCEv_7o3HY2W0130_assertion SIO_000772 19447869 NP387806.RAqRJhYAnXxxTrU310vyfKZX5Ecg-RLHuCEv_7o3HY2W0130_provenance.
- NP387806.RAqRJhYAnXxxTrU310vyfKZX5Ecg-RLHuCEv_7o3HY2W0130_assertion wasDerivedFrom befree-20140225 NP387806.RAqRJhYAnXxxTrU310vyfKZX5Ecg-RLHuCEv_7o3HY2W0130_provenance.
- NP387806.RAqRJhYAnXxxTrU310vyfKZX5Ecg-RLHuCEv_7o3HY2W0130_assertion wasGeneratedBy ECO_0000203 NP387806.RAqRJhYAnXxxTrU310vyfKZX5Ecg-RLHuCEv_7o3HY2W0130_provenance.